Peripheral/Endo

Proximo Medical Announces New Client Win With EMBA

CASTLE PINES, Colo., March 13, 2019 /PRNewswire/ — Proximo Medical today announced that it has been selected as the marketing and commercialization partner of choice for EMBA Medical™ Limited, a medical device company that designs and develops peripheral embolization technologies focused on improving safety, control, and outcomes. Proximo Medical, a revenue-accelerating, risk-sharing, reduced-cost approach to […]

Micro Medical Solutions Signs Distribution Agreements in 15 Countries for MicroStent Vascular Stent

WILMINGTON, Mass., March 12, 2019 /PRNewswire/ — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has established distribution agreements for MicroStent in 15 countries in the European Union and Latin America. MicroStent is a vascular stent specifically […]

Fist Assist Devices, LLC Announces Formation of Global Medical Advisory Board Led by Dialysis Access Center Medical Director Dr. John Ross

LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device start-up based in Silicon Valley, Calif., today announced the formation of its first global medical advisory board (MAB). Fist Assist Devices, LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal […]

Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th

WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that Company management will present at the Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March […]

MIAMI CARDIAC & VASCULAR INSTITUTE BECOMES FIRST IN NORTH AMERICA TO USE NEW ROYAL PHILIPS TECHNOLOGY FOR INTERVENTIONAL PROCEDURES

CORAL GABLES, Fla. – Miami Cardiac & Vascular Institute, the largest and most comprehensive cardiovascular center in the South Florida region, is the first in the United States to use technology it developed, in partnership with Philips, that makes it easier for doctors to perform image guided procedures for heart […]

Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial

CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC Davis Health (“UC Davis”) located in Sacramento, California to be the clinical trial site for the Company’s Phase II clinical trial […]

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced the successful start of its VenoValve® first-in-human study in Bogota, Colombia. The first VenoValve was implanted in a patient and the procedure […]

Philips launches Zenition mobile C-arm platform for enhanced operating room performance and workflow efficiency

AMSTERDAM, Feb. 18, 2019 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Zenition, its new mobile C-arm imaging platform. Mobile C-arms are X-ray systems that are brought into the operating room (OR) to provide live image guidance during a wide range of surgeries including […]

Affluent Medical Releases Impressive Results from Scope 1 Clinical Trial Validating Efficacy of KARDIOZIS Technology

PARIS–(BUSINESS WIRE)–Affluent Medical (Paris:ALAM), a French medtech company specialized in innovative, minimally invasive implants designed to restore key physiological functions for patients suffering from heart and vascular diseases, as well as urinary incontinence, today announces positive results from its SCOPE 1 clinical trial validating the efficacy of KARDIOZIS technology. Results have been […]

Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device

DUBLIN – February 7, 2019 – Medtronic plc (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline(TM) Flex embolization device.1 Previously indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid […]